Publication | Closed Access

Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice

InflammationAnti-inflammatoryAutoimmune DiseaseNovel Nlrp3 InhibitorInflammasome ActivationNlrp3-related DiseasesImmunologyPathologyChronic InflammationAutoimmunityInflammasomeMedicineCell BiologyCell SignalingPhagocyte